omniture

CHRI Signs Joint Market Development Contract with Derentang

China Health Resource, Inc.
2007-10-29 16:40 1191

SUINING, China, Oct. 29 /Xinhua-PRNewswire/ -- China Health Resource, Inc. (OTC Bulletin Board: CHRI) is enhancing cooperation with Derentang by signing a joint development contract of the Chuan DAR market. According to the contract, CHRI will cooperate with Derentang to establish a Chuan DAR Sale Center, specializing in market promotion for Suining Chuan DAR and related processed products. The cooperation will greatly boost the sale of CHRI’s key products. It is predicted that the contract will generate revenue of $ 8,000,000 in the following three years.

Derentang has a 266-year history, famous since the Qing Dynasty of ancient China. It currently has 1200 chain stores in China, with revenue from medicine and healthy foods in 2006 at $ 130 million.

About the Company

China Health Resources Co., Ltd. (CHRI) was incorporated on April 24, 2001. It is one of China’s leading industrialized agricultural corporations. CHRI has focused on the production and further processing of Dahurian Angelica Root (DAR), a herb that is widely used in China, and considered to be an important ingredient in traditional Chinese medicines. CHRI’s business plan includes distributing DAR and the processed products to exploit a large market in the areas of treatment of pain, swelling and pustule. And Good Agricultural Practice (GAP) is a national compulsory criterion for food and drug industries. The goal of GAP is to help agricultural product companies deal with the usual micro-organism harm so as to strengthen the agricultural product safety. CHRI has accomplished the GAP certification of Chuan DAR, making the DAR products and related production technology of the Company become the industry criteria.

Statements regarding financial matters in this press release other than historical facts are ‘forward-looking statements’ within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such proclamations about future expectations, including future revenues and earnings and all other forward-looking statements be subject to the safe harbors created thereby. CHRI depends on outside resources to maintain its continuation. Since these statements involve risks and uncertainties and are subject to change at any time, the company’s actual results may differ materially from expected results.

Source: China Health Resource, Inc.
collection